Lingeng Lu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 68
- Cancer Risks and Factors 20
- Cancer Immunotherapy and Biomarkers 18
- Pancreatic and Hepatic Oncology Research 14
-
- MicroRNA in disease regulation 14
- Cancer-related molecular mechanisms research 8
- Co-authors
- Herbert Yu (42 shared papers)Dionyssios Katsaros (23 shared papers)Harvey A. Risch (31 shared papers)Yingqun Huang (6 shared papers)Irene A. Rigault de la Longrais (7 shared papers)Lei Yan (2 shared papers)Mark S. Kidd (6 shared papers)Amanda Nicole Kallen (2 shared papers)
- Journals
- Breast Cancer Research and Treatment (9 papers)Cancer Epidemiology Biomarkers & Prevention (6 papers)PLoS ONE (6 papers)Cancers (6 papers)Gynecologic Oncology (6 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Lingeng Lu
202 papers receiving 9k citations
Lingeng Lu's Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 2.4k
- Oncology 1.9k
- Obstetrics and Gynecology 767
- Reproductive Medicine 389
- Genetics 997
Countries citing papers authored by Lingeng Lu
This map shows the geographic impact of Lingeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingeng Lu more than expected).
Fields of papers citing papers by Lingeng Lu
This network shows the impact of papers produced by Lingeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingeng Lu. The network helps show where Lingeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs Hit paper breakdown → | 2013 | 938 |
| 2 | Type I and II Endometrial Cancers: Have They Different Risk Factors? Hit paper breakdown → | 2013 | 682 |
| 3 | 2007 | 262 | |
| 4 | 2008 | 229 | |
| 5 | 2015 | 224 | |
| 6 | 2018 | 209 | |
| 7 | 2015 | 206 | |
| 8 | 2018 | 206 | |
| 9 | 2014 | 185 | |
| 10 | 2012 | 156 | |
| 11 | 2010 | 131 | |
| 12 | 2021 | 129 | |
| 13 | 2016 | 125 | |
| 14 | 2010 | 120 | |
| 15 | 2016 | 111 | |
| 16 | 2018 | 104 | |
| 17 | 2011 | 101 | |
| 18 | 2015 | 100 | |
| 19 | 2004 | 90 | |
| 20 | 2009 | 90 |
About Lingeng Lu
Lingeng Lu is a scholar working on Oncology, Cancer Research, Obstetrics and Gynecology, Reproductive Medicine and Genetics, having authored 208 papers that have together received 9.1k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (21 papers), Cancer Risks and Factors (20 papers), Cancer Immunotherapy and Biomarkers (18 papers), Endometrial and Cervical Cancer Treatments (18 papers), Pancreatic and Hepatic Oncology Research (14 papers), MicroRNA in disease regulation (14 papers), Ovarian cancer diagnosis and treatment (13 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (1.9k citations), Obstetrics and Gynecology (767 citations), Reproductive Medicine (389 citations) and Genetics (997 citations). Lingeng Lu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Herbert Yu, Dionyssios Katsaros, Harvey A. Risch, Yingqun Huang, Irene A. Rigault de la Longrais, Lei Yan, Mark S. Kidd, Amanda Nicole Kallen, Jie Xu and Richard I. Gregory. Their work appears in journals such as Breast Cancer Research and Treatment, Cancer Epidemiology Biomarkers & Prevention, PLoS ONE, Cancers and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.